Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Upstream Bio (UPB) Receivables - Other (2023 - 2025)

Historic Receivables - Other for Upstream Bio (UPB) over the last 3 years, with Q3 2025 value amounting to $1.6 million.

  • Upstream Bio's Receivables - Other rose 23484.54% to $1.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.6 million, marking a year-over-year increase of 23484.54%. This contributed to the annual value of $567000.0 for FY2024, which is 31086.96% up from last year.
  • As of Q3 2025, Upstream Bio's Receivables - Other stood at $1.6 million, which was up 23484.54% from $1.7 million recorded in Q2 2025.
  • Upstream Bio's Receivables - Other's 5-year high stood at $1.7 million during Q2 2025, with a 5-year trough of $138000.0 in Q4 2023.
  • For the 3-year period, Upstream Bio's Receivables - Other averaged around $948833.3, with its median value being $869500.0 (2024).
  • Its Receivables - Other has fluctuated over the past 5 years, first soared by 31086.96% in 2024, then skyrocketed by 23484.54% in 2025.
  • Quarter analysis of 3 years shows Upstream Bio's Receivables - Other stood at $138000.0 in 2023, then soared by 310.87% to $567000.0 in 2024, then skyrocketed by 186.42% to $1.6 million in 2025.
  • Its Receivables - Other stands at $1.6 million for Q3 2025, versus $1.7 million for Q2 2025 and $1.2 million for Q1 2025.